Alzheimer's disease: Genes, proteins, and therapy

Physiological Reviews

Volumn 81, Issue 2, 2001, Pages 741-766

  Selkoe, Dennis J ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; GAMMA SECRETASE; NOTCH RECEPTOR; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; CALCIUM HOMEOSTASIS; DOWN SYNDROME; EARLY DIAGNOSIS; GENE MUTATION; GENETIC RISK; GENOTYPE; HUMAN; MISSENSE MUTATION; NEUROFIBRILLARY TANGLE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; REVIEW;

EID: 0035066332     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.2001.81.2.741     Document Type: Review

References (216)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
2. Association between an alpha(2) macroglobulin DNA polymorphism and late-onset Alzheimer's disease
3. Presenilin 1 controls γ-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons
4. Notch signaling: Cell fate control and signal integration in development
5. Lack of apolipprotein E dramatically reduces amyloid β-peptide deposition
6. Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans notch signalling independently of proteolytic processing
7. Hydrogen peroxide mediates amyloid β protein toxicity
8. Aspartate mutations in presenilin and γ-secretase inhibitors both impair Notch1 proteolysis and nuclear translocation with relative preservtion of Notch signaling
9. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q
10. Co-expression of β-amyloid precursor protein (βAPP) and apolipoprotein E in cell culture: Analysis of βAPP processing
11. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
12. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo
13. Mise en evidence immunologique de la protein tau au niveau des lesions de degenerescence neurofibrillaire de la maladie D'Alzheimer
14. Generation of β-amyloid in the secretory pathway in neuronal and non-neuronal cells
15. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100- to 150-kDa molecular mass complex
16. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
17. Alzheimer's Aβ(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells
18. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease
19. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
20. Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease
21. An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos
22. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain
23. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
24. Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein: Cleavage of APP occurs in a late compartment of the default secretion pathway
25. The pathogenesis of senile plaques
26. Alpha2 macroglobulin and the risk of Alzheimer's disease
27. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
28. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
29. Cleavage of amyloid β-peptide during constitutive processing of its precursor
30. Transition-state analog inhibitors of γ-secretase bind directly to Presenilin-1
31. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease
32. The next generation of AD therapeutics: The future is now
33. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
34. Isolation and characterization of an insulin-degrading enzyme from Drosophila melanogaster
35. Aβ-peptide length and apolipoprotein E genotype in Alzheimer's disease
36. Amyloid precursor protein (APP) in the striatum in Alzheimer's disease: An immunohistochemical study
37. Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts
38. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
39. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
40. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
41. The neurofibrillary pathology of Alzheimer's disease
42. Isolation and partial characterization of neurofibrillary tangles and amyloid plaque cores in Alzheimer's disease: Immunohistological studies
43. 42 accumulation in human brain
44. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy
45. LIN-12/Notch signaling: Lessons from worms and flies
46. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
47. Abnormal phosphorylation of the microtubule-associated protein t (tau) in Alzheimer cytoskeletal pathology
48. β-amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms
49. Processing of β-amyloid precursor protein in microglia and astrocytes favors a localization in internal vesicles over constitutive secretion
50. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor
51. Polarized sorting of β-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals
52. Polarized secretion of β-amyloid precursor protein and amyloid β-peptide in MDCK cells
53. The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway
54. Amyloid β-peptide is produced by cultured cells during normal metabolism
55. Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa
56. The Alzheimer family of diseases: Many etiologies, one pathogenesis?
57. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy
58. Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons
59. Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons
60. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene
61. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
62. Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease
63. Contrasting role of presenilin-1 and presenilin-2 in neuronal differentiation in vitro
64. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
65. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice
66. Selective ectodomain phosphorylation and regulated cleavage of β-amyloid precursor protein
67. Identification of a novel aspartic protease (Asp 2) as beta-secretase
68. Association of missense and 5′-splice-site mutations in tau with the inherited FTDP-17
69. The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: Implications for Alzheimer's disease
70. Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease
71. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
72. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome
73. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: Evidence that an initially deposited species is A beta 42(43)
74. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease
75. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease
76. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
77. Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells
78. The transmembrane aspartates in presenilin 1 and 2 are obligatory for γ-secretase activity and amyloid β-protein generation
79. The carboxyl third of tau is tightly bound to paired helical filaments
80. Precursor of amyloid protein in Alzheimer's disease undergoes fast anterograde axonal transport
81. Evidence that production and release of amyloid β-protein involves the endocytic pathway
82. Signal transduction by activated Notch: Importance of proteolytic processing and its regulation by the extracellular domain
83. Microtubule-associated protein, tau, is a major antigenic component of paired helical filaments in Alzheimer's disease
84. Epitopes that span the tau molecule are shared with paired helical filaments
85. Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells
86. Light and electron microscopic localization of presenilin-1 in primate brain
87. 1-42 are potent central nervous system neurotoxins
88. Neurotoxicity induces cleavage of p35 to p25 by calpain
89. A68: A major subunit of paired helical filaments and derivatized forms of normal tau
90. Sequence of deposition of heterogeneous amyloid β-peptides and Apo E in Down syndrome: Implications for initial events in amyloid plaque formation
91. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology
92. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans
93. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene
94. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch-type
95. Candidate gene for the chromosome 1 familial Alzheimer's disease locus
96. Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins
97. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
98. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red
99. 1-antichymotrypsin and apolipoprotein E promote the assembly of the Alzheimer β-protein into filaments
100. Microglial cells and amyloid beta protein (A beta) deposition: Association with A beta 40-containing plaques
101. Amyloid beta protein (A-beta) deposition in chromosome 14-linked Alzheimer's disease: Predominance of A-beta [42(43)]
102. Amyloid plaque core protein in Alzheimer disease and Down syndrome
103. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau
104. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein
105. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
106. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases
107. Reduction of beta-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease
108. 2-macroglobulin with Alzheimer's disease in a Finnish elderly population
109. Apolipoprotein E immunoreactivity in cerebral deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jacob disease
110. Effects of PS1 deficiency on membrane protein trafficking in neurons
111. Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro
112. A role for presenilin-1 in nuclear accumulation of Ire1 fragments and induction of the mammalian unfolded protein response
113. One of the antigenic determinants of paired helical filaments is related to tau protein
114. The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway
115. The β-amyloid binding protein BBP1 mediates cellular vulnerability to aβ by a G protein and caspase-dependent mechanism
116. Inhibition of Alzheimer's beta-amyloid induced vasoactivity and proinflammatory response in microglia by a cGMP-dependent mechanism
117. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
118. Mutagenesis identifies new signals for β-amyloid precursor protein endotycosis, turnover and the generation of secreted fragments, including A42
119. The beta-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity
120. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state
121. 299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue
122. Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier
123. Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier
124. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein
125. Molecular mapping of Alzheimer-type dementia in Down's syndrome
126. Senile plaque neurites fail to demonstrate anti-paired helical filament and antimicrotubule-associated protein-tau immunoreactive proteins in the absence of neurofibrillary tangles in the neocortex
127. Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Aβ1-42/43 expression
128. Cell-surface β-amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an isoform-dependent manner
129. Endoproteolytic processing and stabilization of wild-type and mutant presenilin
130. Cell surface presenilin-1 participates in the gamma-secretase-like proteolysis of notch
131. Evidence for a physical interaction between presenilin and Notch
132. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
133. Complement activation by β-amyloid in Alzheimer disease
134. Inflammation and Alzheimer's disease pathogenesis
135. Chemical characterization of Aβ 17-42 peptide: A component of diffuse amyloid deposits of Alzheimer disease
136. The deletion polymorphism and Val1000lle in alpha-2-macroglobulin and Alzheimer disease in Caribbean Hispanics
137. A Drosophila gene encoding a protein resembling the human β-amyloid precursor protein
138. Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of Cathepsin D
139. Secreted form of amyloid β protein precursor is involved in the growth regulation of fibroblasts
140. Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells
141. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
142. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14
143. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
144. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
145. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
146. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain
147. The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion
148. Endogenous presenilin 1 redistributes to the surface of lamellipodia upon adhesion of Jurkat cells to a collagen matrix
149. Alzheimer's disease: Genotypes, phenotype, and treatments
150. Translating cell biology into therapeutic advances in Alzheimer's disease
151. Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease
152. Alzheimer's disease: Insolubility of partially purified helical filaments in sodium dodecyl sulfate and urea
153. β-amyloid precursor protein of Alzheimer disease occurs as 110-135 kilodalton membrane-associated proteins in neural and nonneural tissues
154. Secretion of β-amyloid precursor protein cleaved at the aminoterminus of the β-amyloid peptide
155. Isolation and quantitation of soluble Alzheimer's β-peptide from biological fluids
156. Skeletal and CNS defects in presenilin-1 deficient mice
157. Cloning of a novel gene bearing missense mutations in early onset familial Alzheimer disease
158. Production of the Alzheimer amyloid β protein by normal proteolytic processing
159. Presenilin 1 P264L knock-in mutation: Effect on cortical neuronal vulnerability to degeneration
160. Purification and cloning of amyloid precursor protein beta-secretase from human brain
161. The protease inhibitory properties of the Alzheimer's β-amyloid precursor protein
162. β-amyloid precursor protein cleavage by a membrane-bound protease
163. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing
164. Expression of a ubiquitous, cross-reactive homologue of the mouse β-amyloid precursor protein (APP)
165. Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein
166. Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations
167. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
168. Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation
169. Amyloidogenic function of the Alzheimer's disease-associated presenilin 1 in the absence of endoproteolysis
170. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
171. Requirements for presenilin-dependent cleavage of notch and other transmembrane proteins
172. Presenilin is required for activity and nuclear access of Notch in Drosophila
173. High tissue content of soluble β1-40 is linked to cerebral amyloid angiopathy
174. Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals
175. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease
176. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles
177. Endoprotreolysis of presenilin 1 and accumulation of processed derivatives in vivo
178. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors
179. Stable association of presenilin derivatives and absence of presenilin interactions with APP
180. β-Amyloid-mediated vasoactivity and vascular endothelial damage
181. Plasma levels of amyloid beta proteins Aβ1-40 and Aβ1-42(43) are elevated in Down's syndrome
182. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue
183. Molecular dissection of domains in mutant presenilin 2 that mediate overproduction of amyloidogenic forms of amyloid beta peptides. Inability of truncated forms of PS2 with familial Alzheimer's disease mutation to increase secretion of Abeta42
184. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: Focusing on phosphatases
185. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
186. Amyloid β-protein fibrillogenesis: Detection of a protofibrillar intermediate
187. The oligomerization of amyloid β-protein begins intracellularly in cells derived from human brain
188. Ectodomain phosphorylation of β-amyloid precursor protein at two distinct cellular locations
189. Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid β-protein precursor
190. Identification, biogenesis and localization of precursors of Alzheimer's disease A4 amyloid protein
191. Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and β-amyloid precursor protein
192. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer's disease
193. A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity
194. Peptidomimetic probes and molecular modeling suggest Alzheimer's γ-secretase is an intramembrane-cleaving aspartyl protease
195. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity
196. Participation of presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation
197. Presenilin 1 is required for Notch 1 and D111 expression in the paraxial mesoderm
198. Neurofibrillary tangles of Alzheimer's disease share antigenic determinants with the axonal microtubule-associated protein tau
199. Evidence for functional and physical association between Caenorhabditis elegans SEL-10, a Cdc4p-related protein, and SEL-12 presenilin
200. Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid β-protein generation
201. Enhanced production and oligomerization of the 42-residue amyloid β-protein by Chinese hamster ovary cells stably expressing mutant presenilins
202. Presenilin 1 regulates the processing APP C-terminal fragments and the generation of amyloid β-protein in ER and Golgi
203. Interaction between amyloid precursor protein and presenilins in mammalian cells: Implications for the pathogenesis of Alzheimer's disease
204. Identification of a novel PSD-95/Dlg/ZO-1 (PDZ)-like protein interacting with the C terminus of presenilin-1
205. Diffuse type of senile plaques in the brains of Alzheimer-type dementia
206. Trafficking of cell surface β-amyloid precursor protein: Retrograde and transcytotic transport in cultured neurons
207. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity
208. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
209. Characterization of Drosophila Presenilin and its colocalization with Notch during development
210. Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants
211. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin
212. Subcellular distribution and turnover of presenilins in transfected cells
213. β-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity
214. Presenilin 1 interaction in the brain with a novel member of the Armadillo family
215. Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: Possible anti-amyloidogenic role of the blood-brain barrier